Top 41 medical and healthcare startups in Paris
Dec 31, 1969
|
Like
11
1
Funding: $816.5M
Doctolib is an online and mobile booking platform that helps to find a specialist doctor nearby and make an appointment.
Doctolib is an online and mobile booking platform that helps to find a specialist doctor nearby and make an appointment.
2
Funding: €666M
Alan wants to make health insurance as simple as subscribing to a software-as-a-service product. It starts with clear pricing and transparent reimbursement policies.
Alan wants to make health insurance as simple as subscribing to a software-as-a-service product. It starts with clear pricing and transparent reimbursement policies.
3
Funding: $393.5M
Cellectis has developed genome editing technology TALEN, which enables it to create more affordable, ready-to-use allogeneic CAR T-cell therapies. Its technology offers protection against graft-versus-host disease, reduces the risk of rejection and improves safety by integrating a self-destruct mechanism. Using this technology, the company is developing a pipeline of several candidates against non-Hodgkin's lymphoma, large B-cell lymphoma, renal cell carcinoma and melanoma. Cellectis is also advancing PulseAgile technology, which uses electroporation (controlled electric fields) to deliver messenger RNA molecules into cells. It utilizes a unique electric field waveform, which, combined with a proprietary buffer solution, allows molecules such as nucleases to effectively penetrate cells while maintaining high cell viability.
Cellectis has developed genome editing technology TALEN, which enables it to create more affordable, ready-to-use allogeneic CAR T-cell therapies. Its technology offers protection against graft-versus-host disease, reduces the risk of rejection and improves safety by integrating a self-destruct mechanism. Using this technology, the company is developing a pipeline of several candidates against non-Hodgkin's lymphoma, large B-cell lymphoma, renal cell carcinoma and melanoma. Cellectis is also advancing PulseAgile technology, which uses electroporation (controlled electric fields) to deliver messenger RNA molecules into cells. It utilizes a unique electric field waveform, which, combined with a proprietary buffer solution, allows molecules such as nucleases to effectively penetrate cells while maintaining high cell viability.
4
Funding: $274.4M
We are a clinical-stage biotechnology company discovering and developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. To address these therapeutic areas, we leverage our integrated development platform by combining a gene therapy-based approach with our core technology platforms of mitochondrial targeting sequence, or MTS, and optogenetics.
We are a clinical-stage biotechnology company discovering and developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. To address these therapeutic areas, we leverage our integrated development platform by combining a gene therapy-based approach with our core technology platforms of mitochondrial targeting sequence, or MTS, and optogenetics.
5
Funding: $219.7M
Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer (OncoMimics™ peptides). Enterome’s pioneering approach to drug discovery is based on its unique ability to decode the interaction between the gut microbiome and the immune system.
Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer (OncoMimics™ peptides). Enterome’s pioneering approach to drug discovery is based on its unique ability to decode the interaction between the gut microbiome and the immune system.
6
Funding: $210M
Tissium invents the next generation of synthetic polymers for tissue reconstruction
Tissium invents the next generation of synthetic polymers for tissue reconstruction
7
Funding: $179.5M
HiFiBiO Therapeutics is biotherapeutics company mobilizing the human immune system to combat disease. We integrate deep-rooted biological expertise with our comprehensive single-cell profiling technologies to rapidly discover and advance a pipeline of antibody drugs to treat cancer and autoimmune disorders. We also aspire to benefit patients through open-innovation partnerships with industry and academia.
HiFiBiO Therapeutics is biotherapeutics company mobilizing the human immune system to combat disease. We integrate deep-rooted biological expertise with our comprehensive single-cell profiling technologies to rapidly discover and advance a pipeline of antibody drugs to treat cancer and autoimmune disorders. We also aspire to benefit patients through open-innovation partnerships with industry and academia.
8
Funding: $170.6M
Wandercraft develops and sells the first exoskeleton to walk self-balanced, for inpatient rehab and outpatient daily life.
Wandercraft develops and sells the first exoskeleton to walk self-balanced, for inpatient rehab and outpatient daily life.
9
Funding: $127.6M
SparingVision is a biotechnology company focused on the discovering and development of an innovative, therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa.
SparingVision is a biotechnology company focused on the discovering and development of an innovative, therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa.
11
Funding: $114.7M
Nabla is the developer of Nabla Copilot, an ambient AI that helps clinicians enjoy care again.
Nabla is the developer of Nabla Copilot, an ambient AI that helps clinicians enjoy care again.
12
Funding: $109.5M
Aqemia is aiming to invent better therapeutic molecules faster. We do that by combining generative AI and quantum-inspired statistical mechanics algorithms to predict affinity between therapeutic target and drugs with experimental accuracy and 10’000 times faster than best softwares.
Aqemia is aiming to invent better therapeutic molecules faster. We do that by combining generative AI and quantum-inspired statistical mechanics algorithms to predict affinity between therapeutic target and drugs with experimental accuracy and 10’000 times faster than best softwares.
13
Funding: €91M
SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications.
SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications.
14
Funding: $91.2M
Resilience Care is building a software-based solution for cancer treatment providers and patients.
Resilience Care is building a software-based solution for cancer treatment providers and patients.
15
Funding: $89M
Lifen aims to improve the quality of healthcare by facilitating access to digital innovation, benefiting both doctors and patients. The startup has built its success up to now on the digitization of medical reports, based on proven technologies, and fulfilling the most stringent security requirements.
Lifen aims to improve the quality of healthcare by facilitating access to digital innovation, benefiting both doctors and patients. The startup has built its success up to now on the digitization of medical reports, based on proven technologies, and fulfilling the most stringent security requirements.
16
Funding: $74.7M
A unique platform to engineer and intervene on the microbiome. Eligobiotics are a platform technology that can be programmed to leverage the existing microbial populations in the gut, lungs, vagina, skin, etc. This technology can enable a targeted diagnosis, editing, and functionalization of human or animal microbiomes.
A unique platform to engineer and intervene on the microbiome. Eligobiotics are a platform technology that can be programmed to leverage the existing microbial populations in the gut, lungs, vagina, skin, etc. This technology can enable a targeted diagnosis, editing, and functionalization of human or animal microbiomes.
17
Funding: $66.9M
Mauna Kea Technologies specializes in designing, developing, and selling optical biopsy devices and tools.
Mauna Kea Technologies specializes in designing, developing, and selling optical biopsy devices and tools.
18
Funding: €49.3M
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
19
Funding: $44.7M
Gleamer develops an AI-powered software to enhance radiologists’ productivity.
Gleamer develops an AI-powered software to enhance radiologists’ productivity.
21
Funding: $35.5M
Inato allows sponsors and CROs to predict and tailor their recruitment strategy before the launch of clinical trials to reduce timelines.
Inato allows sponsors and CROs to predict and tailor their recruitment strategy before the launch of clinical trials to reduce timelines.
22
Funding: €32.6M
Incepto Medical is a Medical imaging solution based on artificial intelligence
Incepto Medical is a Medical imaging solution based on artificial intelligence
23
Funding: $27.5M
Implicity developed a universal remote monitoring platform for cardiac patients with connected pacemakers and implantable defibrillators.
Implicity developed a universal remote monitoring platform for cardiac patients with connected pacemakers and implantable defibrillators.
24
Funding: $25.8M
Chipiron is a company that designs, manufactures, and markets a new generation of portable, inexpensive and powerful MRI machines.
Chipiron is a company that designs, manufactures, and markets a new generation of portable, inexpensive and powerful MRI machines.
25
Funding: €22M
To treat Aortic Stenosis, Cardiawave has developed a non-invasive, real-time image-guided medical device using a cutting-edge ultrasound technology, known as Pulsed Cavitational Ultrasound Therapy (PCUT).
To treat Aortic Stenosis, Cardiawave has developed a non-invasive, real-time image-guided medical device using a cutting-edge ultrasound technology, known as Pulsed Cavitational Ultrasound Therapy (PCUT).
26
Funding: $23.1M
By applying the latest research in Artificial intelligence, Cardiologs provides a web solution to streamline this process at large scale, enabling the highest diagnostic yield, for the least physician effort.
By applying the latest research in Artificial intelligence, Cardiologs provides a web solution to streamline this process at large scale, enabling the highest diagnostic yield, for the least physician effort.
27
Funding: $23M
Zoī is a science-backed holistic approach for health and wellness. Zoi wants to give you personalized insights so that you can improve your overall health over the long run.
Zoī is a science-backed holistic approach for health and wellness. Zoi wants to give you personalized insights so that you can improve your overall health over the long run.
28
Funding: $21.2M
AZmed offers powerful AI-aided diagnosis tool that detects all types of fractures in radiography
AZmed offers powerful AI-aided diagnosis tool that detects all types of fractures in radiography
30
Funding: €17.5M
Moka.care is a firm that provides a complete solution for allowing your employees to take care of their mental health.
Moka.care is a firm that provides a complete solution for allowing your employees to take care of their mental health.
31
Funding: €15M
Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features.
Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features.
32
Funding: €12M
Teale is a leading digital mental health platform, that combines psychology & technology, allowing people to take care of their mental health, and company to grow sustainably Teale provides personalized interactive and engaging digital health care.
Teale is a leading digital mental health platform, that combines psychology & technology, allowing people to take care of their mental health, and company to grow sustainably Teale provides personalized interactive and engaging digital health care.
33
Funding: €11.8M
Wefight is a conversational interface Vik automates outpatient follow-up of cancer patients.
Wefight is a conversational interface Vik automates outpatient follow-up of cancer patients.
36
Funding: €4.7M
VitaDX is developing a non-invasive, AI-based test for the early detection of bladder cancer. It is based on VisioCyt technology, which uses deep learning and computer vision algorithms to analyze and diagnose digital cytology specimens. The test can be performed using a simple urine sample or screening data (for asymptomatic, high-risk patients). The company also offers the VisioCyt Thyroid test for diagnosing thyroid cancer using fine-needle aspiration biopsy.
VitaDX is developing a non-invasive, AI-based test for the early detection of bladder cancer. It is based on VisioCyt technology, which uses deep learning and computer vision algorithms to analyze and diagnose digital cytology specimens. The test can be performed using a simple urine sample or screening data (for asymptomatic, high-risk patients). The company also offers the VisioCyt Thyroid test for diagnosing thyroid cancer using fine-needle aspiration biopsy.
38
Funding: €2M
Klineo is a platform that provides an intuitive and intelligent clinical trial search for oncology patients and doctors.
Klineo is a platform that provides an intuitive and intelligent clinical trial search for oncology patients and doctors.
39
Carenity is a digital patient platform that provides direct, timely and compliant access to patient real-world data.
40
Chronolife builds predictive medical solutions to aid in diagnosis through a wireless, wearable technology.
41
Psyhelp offers a friendly, safe Mental Health and Wellbeing space with many science-backed CBT tools, which personalize as you go to meet your needs.
★
See also:
